TGEN Tecogen Inc

Targeted Genetics Invites You to Join Its Third Quarter 2004 Earnings Call on the Web SEATTLE, Nov. 1 /PRNewswire-FirstCall/ -- Targeted Genetics Corporation (NASDAQ:TGEN) invites you to listen to its investor and analyst conference call, which will be held in conjunction with the release of the Company's Third Quarter 2004 financial results. The call will be broadcast live over the Internet on Thursday, November 4, 2004, at 10:30 a.m. EST. What: Targeted Genetics Corporation Third Quarter 2004 Financial Results When: November 4, 2004, 10:30 a.m. EST Where: http://www.targetedgenetics.com/ If you are unable to participate during the live webcast, the call will be archived for 30 days at http://www.targetedgenetics.com/. The replay also will be available for 30 days by dialing 800-207-7077 (domestic) or 913-383-5767 (international) and using PIN #4074. Targeted Genetics Corporation develops gene-based products for preventing and treating acquired and inherited diseases. The Company has three clinical product development programs, targeting cystic fibrosis, AIDS prophylaxis and rheumatoid arthritis. The Company also has a promising pipeline of product candidates focused on hemophilia and cancer, and a broad platform of gene delivery technologies for application in nucleic acid-based drug development. For more information about Targeted Genetics, visit its website at http://www.targetedgenetics.com/. NOTE: This release contains forward-looking statements regarding our product pipeline and clinical trials. These statements involve current expectations, forecasts of future events and other statements that are not historical facts. Inaccurate assumptions and known and unknown risks and uncertainties can affect the accuracy of forward-looking statements. Actual results could differ materially from expectations for a number of reasons, including our failure to make progress with our clinical trials, our failure to obtain positive results from our preclinical programs, our failure to obtain regulatory approval and the other risks described in the section entitled "Factors Affecting Our Operating Results, Our Business and Our Stock Price" in our quarterly report on Form 10-Q for the quarter ended June 30, 2004. You should not rely unduly on these forward-looking statements, which apply only as of the date of this release. We undertake no duty to publicly announce or report revisions to these statements as new information becomes available that may change our expectations. DATASOURCE: Targeted Genetics Corporation CONTACT: Courtney Self of Targeted Genetics Corporation, +1-206-521-7392 Web site: http://www.targetedgenetics.com/

Copyright